Ewers, K.M.; Patil, S.; Kopp, W.; Thomale, J.; Quilitz, T.; Magerhans, A.; Wang, X.; Hessmann, E.; Dobbelstein, M.
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Cancers 2021, 13, 6163.
https://doi.org/10.3390/cancers13246163
AMA Style
Ewers KM, Patil S, Kopp W, Thomale J, Quilitz T, Magerhans A, Wang X, Hessmann E, Dobbelstein M.
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Cancers. 2021; 13(24):6163.
https://doi.org/10.3390/cancers13246163
Chicago/Turabian Style
Ewers, Katharina M., Shilpa Patil, Waltraut Kopp, Jürgen Thomale, Tabea Quilitz, Anna Magerhans, Xin Wang, Elisabeth Hessmann, and Matthias Dobbelstein.
2021. "HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells" Cancers 13, no. 24: 6163.
https://doi.org/10.3390/cancers13246163
APA Style
Ewers, K. M., Patil, S., Kopp, W., Thomale, J., Quilitz, T., Magerhans, A., Wang, X., Hessmann, E., & Dobbelstein, M.
(2021). HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Cancers, 13(24), 6163.
https://doi.org/10.3390/cancers13246163